Literature DB >> 32107726

Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes.

Megan N Landis1,2.   

Abstract

Acne vulgaris is the most common skin disease treated by dermatologists. It can be severe and result in permanent scars. Isotretinoin is the most effective treatment for acne and has the potential for long-term clearance. Prescribing and monitoring protocols can vary widely among prescribers. Recent studies, reports, and consensus statements help shed light on optimizing the use of isotretinoin for acne. A recent literature review is summarized in this article to help the practitioner optimize isotretinoin use for acne. The article outlines the advantages and disadvantages of standard, high-dose, and low-dose isotretinoin regimens; discusses the current status of controversies surrounding isotretinoin (including depression/suicide, pregnancy, and inflammatory bowel disease); reviews monitoring recommendations and treatment for hypertriglyceridemia and elevated transaminase levels; and discusses common adverse effects seen with isotretinoin, along with their treatment and prevention.

Entities:  

Year:  2020        PMID: 32107726     DOI: 10.1007/s40257-020-00508-0

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  6 in total

1.  A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.

Authors:  James Q Del Rosso; Sandra Marchese Johnson; Todd Schlesinger; Lawrence Green; Nestor Sanchez; Edward Lain; Zoe Draelos; Jean-Philippe York; Rajeev Chavda
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

2.  Genome-wide association meta-analysis identifies 29 new acne susceptibility loci.

Authors:  Brittany L Mitchell; Jake R Saklatvala; Nick Dand; Fiona A Hagenbeek; Xin Li; Josine L Min; Laurent Thomas; Meike Bartels; Jouke Jan Hottenga; Michelle K Lupton; Dorret I Boomsma; Xianjun Dong; Kristian Hveem; Mari Løset; Nicholas G Martin; Jonathan N Barker; Jiali Han; Catherine H Smith; Miguel E Rentería; Michael A Simpson
Journal:  Nat Commun       Date:  2022-02-07       Impact factor: 14.919

3.  Effect of Evening Primrose Oil Supplementation on Biochemical Parameters and Nutrition of Patients Treated with Isotretinoin for Acne Vulgaris: A Randomized Double-Blind Trial.

Authors:  Agnieszka Kaźmierska; Izabela Bolesławska; Paweł Jagielski; Adriana Polańska; Aleksandra Dańczak-Pazdrowska; Grzegorz Kosewski; Zygmunt Adamski; Juliusz Przysławski
Journal:  Nutrients       Date:  2022-03-23       Impact factor: 5.717

4.  The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.

Authors:  Juan Farfán; John M Gonzalez; Martha Vives
Journal:  PeerJ       Date:  2022-07-25       Impact factor: 3.061

5.  Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.

Authors:  Agnieszka Kaźmierska; Izabela Bolesławska; Adriana Polańska; Aleksandra Dańczak-Pazdrowska; Paweł Jagielski; Sławomira Drzymała-Czyż; Zygmunt Adamski; Juliusz Przysławski
Journal:  Nutrients       Date:  2022-07-21       Impact factor: 6.706

6.  Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data.

Authors:  Tapio Paljarvi; Tess McPherson; Sierra Luciano; Kimmo Herttua; Seena Fazel
Journal:  Br J Dermatol       Date:  2022-04-12       Impact factor: 11.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.